Study Notes on Early Maladaptive Schemas and Intolerance of Uncertainty in GAD

Study Notes on Early Maladaptive Schemas and Intolerance of Uncertainty in Generalized Anxiety Disorder

Article Details

  • Authors: Jessica A. Riley, Emily J. Wilson, Alice R. Norton, Maree J. Abbott

  • Published in: British Journal of Clinical Psychology

  • DOI: 10.1111/bjc.70012

  • License: Open Access under Creative Commons Attribution-NonCommercial-NoDerivs License

Introduction to Generalized Anxiety Disorder (GAD)

  • Definition: GAD is characterized by excessive anxiety and worry about multiple situations or events, difficult to control, leading to chronic distress or impairment (DSM-5-TR; APA, 2022).

  • Prevalence: Lifetime prevalence of GAD is approximately 3.70% (Ruscio et al., 2017).

  • Treatment: Cognitive Behavioral Therapy (CBT) is considered the gold-standard treatment (Newman et al., 2022).

    • Recent meta-analysis indicates a large effect for psychological treatment and a medium effect for pharmacotherapy (Carl et al., 2020).

  • Treatment Effectiveness: Around 50% of individuals receiving treatment continue to meet diagnostic criteria post-treatment (Fisher, 2006; Springer et al., 2018).

Study Objectives

  • Investigate the relationship between several variables related to GAD:

    • Adverse Childhood Experiences (ACEs)

    • Dysfunctional parental styles

    • Intolerance of Uncertainty (IoU)

    • Early Maladaptive Schemas (EMS)

  • Comparison between a low anxiety group and those with clinical GAD to explore differences in GAD symptoms and diagnostic status.

Hypotheses

  • The low anxiety group is expected to score significantly lower on ACEs, dysfunctional parental styles, IoU, and EMS than the clinical GAD group.

Methods

Participants

  • Total of 186 participants:

    • Clinical GAD Group: 38 participants (diagnosed with GAD based on the DSM-5-TR).

    • Low Anxiety Group: 148 undergraduate students with normal to mild anxiety scores on DASS-21 and normal on GAD-7.

  • Exclusion Criteria: Non-English speakers or under 18 years old.

Measurements

  • Clinical Measures:

    • DIAMOND (Tolin et al., 2018): Used for assessing clinical status (good reliability).

    • DASS-21: Measures depression, anxiety, and stress (α ranges from .78 to .91).

    • GAD-7: Assesses generalized anxiety symptoms (α = .91).

    • CTQ-SF: Measures childhood trauma (internal consistency .42 to .92).

    • MOPS: Measures parental styles (internal consistency .78 to .89).

    • IUS-12: Evaluates IoU (internal consistency α = .93).

    • YSQ-R: Assesses 20 EMSs across 5 domains with internal consistency from .78 to .91.

Statistical Analysis

  • Conducted using SPSS, version 29.01.0.

  • Analyzed demographic information and group mean differences using MANCOVA and other relevant tests to understand GAD symptomatology and predisposing factors.

  • Hierarchical regression and logistic regression analyses identified predictors of GAD.

Results

Key Findings

  • Predictions: IoU and EMSs of vulnerability to harm and self-sacrifice predicted GAD-7 scores significantly.

  • Demographics: Significant differences in age, gender, and educational levels between the clinical GAD and low anxiety groups were noted.

  • Regression Outcomes: IoU and the EMS of vulnerability to harm were significant predictors of membership in the clinical GAD group.

Comparison of Groups on Key Measures

  • MANCOVA showed clinical GAD group scored significantly higher on:

    • ACE subscales (except physical neglect)

    • Experiences of parental indifference and abuse

    • IoU and multiple EMSs (significant variations noted across 18 of the 20 EMSs).

  • No significant differences on approval-seeking and pessimism scores between groups.

Discussion

Implications of Findings

  • Illustrates the key role IoU and specific EMSs play in exacerbating GAD.

  • The findings support the concept of integrating childhood adverse experiences and dysfunctional parenting in models of GAD.

  • Clinical Recommendations:

    • Therapies targeting IoU and specific EMSs (particularly vulnerability to harm and self-sacrifice) could enhance treatment outcomes for GAD.

    • Schemas addressing unmet early life needs could be incorporated into treatment paradigms using Schema Therapy.

Study Limitations

  • Absence of a diagnosed control group limits diagnostic contrast validity.

  • Recruitment bias may have affected the demographic composition of the sample, especially given disproportionate group sizing.

  • The cross-sectional nature limits causal interpretations, and a longitudinal study design is suggested for future research.

Conclusion

  • The study underscores the importance of integrating developmental factors in the understanding and treatment of GAD.

  • Future Directions: Further research is warranted to explore treatment efficacy targeting IoU and EMSs in GAD populations.

Generalized Anxiety Disorder (GADGAD) is characterized by persistent, excessive anxiety and uncontrollable worry regarding various areas of life, as defined by the DSM−5−TRDSM-5-TR. It occurs in approximately 3.70%3.70\% of the population during their lifetime and results in chronic distress or functional impairment.

Symptoms of Generalized Anxiety Disorder

When drafting the symptoms section, focus on the core criteria while paraphrasing:

  • Excessive Worry: Identifying that the anxiety is disproportionate to the actual likelihood or impact of the anticipated event.

  • Lack of Control: The individual finds it difficult to shift their focus away from the worry.

  • Physical and Cognitive Indicators: These often include restlessness, fatigue, difficulty concentrating, irritability, muscle tension, and sleep disturbances.

Environmental and Developmental Factors (Source: Riley et al., 2022)

This study is a valuable peer-reviewed source for the 'Non-Genetic/Environmental' section of the essay. Significant findings include:

  1. Adverse Childhood Experiences (ACEsACEs): There is a strong relationship between childhood trauma (excluding physical neglect) and clinical GADGAD status.

  2. Dysfunctional Parenting: Parental indifference and experiences of abuse in early life are identified as key factors that predispose individuals to anxiety disorders.

  3. Early Maladaptive Schemas (EMSEMS): These are psychological constructs formed in childhood. Specifically, 'vulnerability to harm' and 'self-sacrifice' schemas are significant predictors of high anxiety scores.

  4. Intolerance of Uncertainty (IoUIoU): A key cognitive factor where individuals find the lack of predictability in life inherently stressful, often linked to their developmental history.

Effective Treatment Modalities

The notes identify two primary treatment approaches that can be used for the 'Treatment' section:

  • Cognitive Behavioral Therapy (CBTCBT): Currently considered the gold-standard treatment, showing a large effect size in reducing psychological distress. It focuses on identifying and challenging maladaptive thought patterns.

  • Schema Therapy: This is an innovative approach that targets unmet early life needs. By addressing specific schemas (like vulnerability to harm) and increasing a patient's tolerance for uncertainty, this method helps improve long-term functioning for the 50%50\% of patients who may not fully recover with CBTCBT alone.

  • Note on Pharmacotherapy: While effective, research indicates it generally has a medium effect size compared to the larger effect of psychological interventions.